| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | Chief Executive Officer
2 companies
Jeffrey S Ervin is Chief Executive Officer at BACK and has filed Form 4s across 2 companies. Jeffrey S Ervin's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $170K at current prices.
The biggest single holding is ALLR (~$169K) as CFO.
Jeffrey S Ervin has 12 Form 4 filings on record from February 2019 to January 2026, across 3 companies: CFO at Allarity Therapeutics (ALLR), 2026; Director at Cingulate (CING), 2024–2025; Chief Executive Officer at Imac (BACK), 2019–2022.
The 23 reported transactions were 10 open-market purchases, 7 option or other derivative awards, 3 option exercises and 1 stock award, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $8K and no sales.
The largest open-market purchase was 5,000 shares of BACK at an average $0.78 on September 10, 2020, about $4K.